Lorenna Buck
Partner
Boston
Lorenna Buck is a core member of the Private Equity practice at Boston Consulting Group. She has deep experience in private equity due diligence and growth strategy across a variety of industries such as consumer goods, industrial goods, and health care.
Lorenna has worked with clients on a wide range of strategic topics, including due diligence (sell- and buy-side) and post-merger integrations; growth strategy and M&A strategy; and organizational effectiveness.
Prior to joining BCG, Lorenna worked in R&D Strategic Intelligence at AstraZeneca Pharmaceuticals. Lorenna also served on the Board of Directors for the Harvard/MIT Coop Bookstore where she focused on real estate, partnership, and consumer insight strategies.
Championing inclusiveness at the highest levels of portfolio companies is the right moral choice—and it has practical benefits, too.
A market study delivers an independent, objective assessment to potential buyers of the market, the competitive position, and the growth prospects of a divestiture candidate. It also helps private equity firms prep portfolio companies and their senior management for transactions, in many cases revealing possible strategic moves that could make a company more desirable.
